| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 20.991 | 32.272 | 37.441 | 55.577 | 70.637 | 69.292 | 80.649 | 128.750 | 142.515 |
| Total Income - EUR | - | 20.997 | 35.935 | 38.472 | 55.580 | 74.059 | 73.428 | 80.652 | 128.817 | 143.169 |
| Total Expenses - EUR | - | 11.644 | 26.758 | 28.755 | 35.131 | 40.815 | 46.417 | 36.131 | 41.029 | 48.830 |
| Gross Profit/Loss - EUR | - | 9.354 | 9.176 | 9.716 | 20.448 | 33.244 | 27.011 | 44.521 | 87.788 | 94.339 |
| Net Profit/Loss - EUR | - | 9.144 | 8.853 | 9.332 | 19.893 | 32.783 | 26.318 | 43.714 | 86.500 | 90.044 |
| Employees | - | 1 | 4 | 4 | 3 | 3 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Nicorcris Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 159 | 886 | 870 | 853 | 30.021 | 25.457 | 23.347 | 20.054 | 54.118 |
| Current Assets | - | 10.308 | 10.215 | 10.099 | 24.618 | 23.817 | 8.113 | 33.117 | 69.367 | 39.268 |
| Inventories | - | 0 | 264 | 844 | 0 | 0 | 864 | 0 | 670 | 8.506 |
| Receivables | - | 2.788 | 3.281 | 2.746 | 4.250 | 6.644 | 5.386 | 11.957 | 44.592 | 1.487 |
| Cash | - | 7.520 | 6.671 | 6.509 | 20.369 | 17.173 | 1.863 | 21.160 | 24.105 | 29.275 |
| Shareholders Funds | - | 9.188 | 9.129 | 9.599 | 24.046 | 50.853 | 32.421 | 43.763 | 86.549 | 90.092 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.279 | 1.972 | 1.370 | 1.426 | 2.985 | 1.149 | 12.701 | 2.872 | 3.294 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nicorcris Med Srl